OCULAR CHANGES IN METASTATIC MELANOMA PATIENTS TREATED WITH MEK INHIBITOR COBIMETINIB AND BRAF INHIBITOR VEMURAFENIB. Radiology and Oncology, v. 52, n. 2, 23 May2018.